232 related articles for article (PubMed ID: 37831728)
1. Effect of miR-34a on the expression of clock and clock-controlled genes in DLD1 and Lovo human cancer cells with different backgrounds with respect to p53 functionality and 17β-estradiol-mediated regulation.
Moravčík R; Olejárová S; Zlacká J; Herichová I
PLoS One; 2023; 18(10):e0292880. PubMed ID: 37831728
[TBL] [Abstract][Full Text] [Related]
2. 2.4 GHz Electromagnetic Field Influences the Response of the Circadian Oscillator in the Colorectal Cancer Cell Line DLD1 to miR-34a-Mediated Regulation.
Olejárová S; Moravčík R; Herichová I
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361993
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
[TBL] [Abstract][Full Text] [Related]
5. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
6. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
7. miR-34a-dependent overexpression of Per1 decreases cholangiocarcinoma growth.
Han Y; Meng F; Venter J; Wu N; Wan Y; Standeford H; Francis H; Meininger C; Greene J; Trzeciakowski JP; Ehrlich L; Glaser S; Alpini G
J Hepatol; 2016 Jun; 64(6):1295-304. PubMed ID: 26923637
[TBL] [Abstract][Full Text] [Related]
8. microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.
Wang X; Dong K; Gao P; Long M; Lin F; Weng Y; Ouyang Y; Ren J; Zhang H
Cancer Biother Radiopharm; 2013 Feb; 28(1):45-50. PubMed ID: 23036084
[TBL] [Abstract][Full Text] [Related]
9. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
[TBL] [Abstract][Full Text] [Related]
10. Expression of senescence-associated microRNAs and target genes in cellular aging and modulation by tocotrienol-rich fraction.
Khee SG; Yusof YA; Makpol S
Oxid Med Cell Longev; 2014; 2014():725929. PubMed ID: 25132913
[TBL] [Abstract][Full Text] [Related]
11. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
[TBL] [Abstract][Full Text] [Related]
12. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis.
Hu Z; Fan H; Lv G; Zhou Q; Yang B; Zheng J; Cao W
J Dermatol Sci; 2015 Aug; 79(2):155-62. PubMed ID: 25982144
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.
Wu J; Liang W; Tian Y; Ma F; Huang W; Jia Y; Jiang Z; Wu H
J Cell Mol Med; 2019 May; 23(5):3538-3548. PubMed ID: 30793480
[TBL] [Abstract][Full Text] [Related]
15. miR-34a repression of SIRT1 regulates apoptosis.
Yamakuchi M; Ferlito M; Lowenstein CJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13421-6. PubMed ID: 18755897
[TBL] [Abstract][Full Text] [Related]
16. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
[TBL] [Abstract][Full Text] [Related]
17. MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.
Li L; Yuan L; Luo J; Gao J; Guo J; Xie X
Clin Exp Med; 2013 May; 13(2):109-17. PubMed ID: 22623155
[TBL] [Abstract][Full Text] [Related]
18. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M
Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA HNF1A-AS1 mediated repression of miR-34a/SIRT1/p53 feedback loop promotes the metastatic progression of colon cancer by functioning as a competing endogenous RNA.
Fang C; Qiu S; Sun F; Li W; Wang Z; Yue B; Wu X; Yan D
Cancer Lett; 2017 Dec; 410():50-62. PubMed ID: 28943452
[TBL] [Abstract][Full Text] [Related]
20. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
